WASHINGTON, Feb. 25 The Food and Drug Administration published the following rule in the Federal Register for approval of New Animal Drug applications and withdrawal of approval of New Animal Drug Applications:. Where applicable, FDA is also withdrawing approval of those parts of the NADAs that pertain to use of these antimicrobial drugs for prod
Where applicable, FDA is also withdrawing approval of those parts of the NADAs that pertain to use of these antimicrobial drugs for production indications. FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5689, firstname.lastname@example.org.
New Pharmaceutical Science Study Findings Recently Were Reported by T. Nayir and Co-Researchers. According to news reporting out of Mersin, Turkey, by NewsRx editors, research stated, "The concepts of' essential drugs' and' national drug policy' described by the World Health Assembly in 1975 were the first steps taken towards the rational use of dr
Novartis International AG/ Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC. *FDA also grants Breakthrough Therapy designation based on Phase III data in. brain* If approved in the first-line setting, Zykadia will offer previously untreated ALK+ metastatic NSCLC patients a new treatment op
Novartis today announced that the US Food and Drug Administration accepted the Company's supplemental New Drug Application for filing, and granted Priority Review for the expanded use of Zykadia as a first-line treatment for patients with metastatic non-small cell lung cancer whose tumors are anaplastic lymphoma kinase- positive as detected by
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Regulation FD Disclosure Item7.01. Regulation FD Disclosure. On February23, 2017, Provectus Biopharmaceuticals, Inc. (the Company) issued a press release (the Press Release) announcing the appointment of Bruce Horowitz and Dominic Rodrigues as strategic advisors to the Board of Director
Nutra Pharma Corporation, a biotechnology company developing drugs for the treatment of Multiple Sclerosis and HIV that also markets Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, announced today that Global Small Caps has initiated coverage of the Company including operations and overall shareholder value.
Release date- 20022017- Local manufacture of drugs presents pharmaceutical industry with business opportunity of $40.8 billion, finds Frost& Sullivan. The growing incidence of more Western lifestyle diseases such as cardiovascular disease, cancer, diabetes and respiratory disease, in addition to infectious and parasitic illness, will present the...
Otsuka Pharmaceutical will launch OATHAS* 2 to assist pharmacies and pharmacists in supporting the health of their local communities. The unique program combines knowledge acquired from Otsuka Pharmaceutical product research and development and public awareness activities with the expertise of nonprofit organization HAP* 3 in creating local...
Perrigo Company plc today announced that its Board of Directors declared a quarterly dividend of $0.16 per share, payable on March 21, 2017 to shareholders of record on March 3, 2017. About Perrigo Perrigo Company plc, a leading global over-the-counter consumer goods and pharmaceutical company, offers patients and customers high quality products
By Caroline Pomeyie, GNA Accra, Feb. 20, GNA- Mr. Isaac Adupong, Greater Accra Regional Chairman of the Pharmaceutical Society of Ghana has reminded health professionals that selling of expired drugs to patients was illegal and criminal transgression. Isaac Adupong, Greater Accra Regional Chairman of the Pharmaceutical Society of Ghana has reminded
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "MEDA CONSUMER HEALTHCARE" by Mylan Inc. IP Department- Trademarks, representing Mylan. This application was made available to the public on February 07, 2017.
2016 was a profitable year for Vietnam's biggest pharmaceutical firms, making the lucrative industry more appealing for international groups. Vietnam's biggest publicly traded drug maker, Hau Giang Pharmaceutical JSC, made a consolidated pre-tax profit of VND756.65 billion in 2016, up 20.29 per cent on year, while its consolidated net revenue climb
By a News Reporter-Staff News Editor at Pharma Business Week- Global demand for labels in pharmaceutical applications is projected to increase 7.1 percent annually to 5.1 billion square meters in 2020, the fastest growth rate among major label markets. These and other trends are presented in HYPERLINK "...
By Caroline Pomeyie, GNA Accra, Feb. 20, GNA- Mr. Isaac Adupong, Greater Accra Regional Chairman of the Pharmaceutical Society of Ghana has reminded health professionals that selling of expired or almost expired drugs to patients was illegal and criminal transgression. Isaac Adupong, Greater Accra Regional Chairman of the Pharmaceutical Society of
Dublin- Research and Markets has announced the addition of the "Smoking Cessation- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering. Smoking Cessation- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales,
Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:. African Pharmaceuticals Market, Forecast to 2020, part of Frost& Sullivan's Life Sciences Growth Partnership Service program, provides valuable insights for Big Ph